Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.
复制标题
DOI:
10.1038/nature09707
复制
发表时间:
2011-02-24
期刊:
影响因子:
64.8
通讯作者:
Karin, Michael
中科院分区:
文献类型:
--
作者:
Tan, Wei;Zhang, Weizhou;Strasner, Amy;Grivennikov, Sergei;Cheng, Jin Q.;Hoffman, Robert M.;Karin, Michael
Inflammatory mechanisms influence tumor development and metastatic progression. Of interest is the role of such mechanisms in metastatic spread of tumors whose etiology does not involve pre-existing inflammation or infection, such as breast and prostate cancers. We found that prostate cancer metastasis is associated with lymphocyte infiltration into advanced tumors and elevated expression of the tumor necrosis factor (TNF) family members receptor activator of NF-κB (RANK) ligand (RANKL) and lymphotoxin (LT). But the source of RANKL and its role in metastasis were not established. RANKL and its receptor RANK control proliferation of mammary lobuloalveolar cells during pregnancy through activation of IκB kinase α (IKKα), a protein kinase that is required for self-renewal of mammary cancer progenitors and prostate cancer metastasis. We therefore examined whether RANKL, RANK and IKKα are also involved in mammary/breast cancer metastasis. Indeed, RANK signaling in mammary carcinoma cells that overexpress the ErbB2 (c-Neu) proto-oncogene, which is frequently amplified in metastatic human breast cancers, was important for pulmonary metastasis. Metastatic spread of ErbB2-transformed carcinoma cells was also dependent on CD4+CD25+ T cells, whose major pro-metastatic function appeared to be RANKL production. RANKL-producing T cells were mainly FoxP3+ and found in close proximity to smooth muscle actin (SMA)-positive stromal cells in mouse and human breast cancers. The T cell-dependence of pulmonary metastasis was replaced by administration of exogenous RANKL, a procedure that also stimulated pulmonary metastasis of RANK-positive human breast carcinoma cells. These results are consistent with the adverse prognostic impact of tumor-infiltrating CD4+ or FoxP3+ T cells on human breast cancer and suggest that targeting of RANKL-RANK signaling can be used in conjunction with other therapies to prevent subsequent metastatic disease.
登录
查看更多内容
DOI:
10.1084/jem.20042167
发表时间:
2005-05-16
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Ercolini AM;Ladle BH;Manning EA;Pfannenstiel LW;Armstrong TD;Machiels JP;Bieler JG;Emens LA;Reilly RT;Jaffee EM
通讯作者:
Jaffee EM
影响因子:
11.2
作者:
Gobert, Michael;Treilleux, Isabelle;Menetrier-Caux, Christine
通讯作者:
Menetrier-Caux, Christine
影响因子:
15.3
作者:
Gao, J L;Kuhns, D B;Tiffany, H L;McDermott, D;Li, X;Francke, U;Murphy, P M
通讯作者:
Murphy, P M
影响因子:
64.8
作者:
Jones, DH;Nakashima, T;Penninger, JM
通讯作者:
Penninger, JM
影响因子:
3.7
作者:
Liao D;Luo Y;Markowitz D;Xiang R;Reisfeld RA
通讯作者:
Reisfeld RA